Malignancy and lymphoid proliferation in primary immune deficiencies; hard to define, hard to treat.
Ayça KiykimNursah EkerOzlem SurekliErcan NainNurhan KasapHacer AktürkOmer DogruAylin CanbolatAyper SomerAhmet KocGulnur TokucSuheyla BozkurtKemal TurkozElif Karakoç AydınerAhmet OzenSafa BarışPublished in: Pediatric blood & cancer (2019)
In patients with PIDs, malignancy may occur and negatively affect the OS. The diagnosis can be challenging in the presence of nonneoplastic lymphoproliferative disease or bone marrow abnormalities. Awareness of susceptibility to malignant transformation and early diagnosis with multidisciplinary approach can save the patients' lives.